Orexigen Therapeutics is a biopharmaceutical company developing treatments for obesity founded in 2002 by Eckard Weber.
3
Funding Rounds
$76.0m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Ec**** We*** |
|
- |